Global Allergic Rhinitis Drugs Market Research Report 2023

Report ID: 1983193 | Published Date: Jan 2025 | No. of Page: 120 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Allergic Rhinitis Drugs Market Overview
    1.1 Product Overview and Scope of Allergic Rhinitis Drugs
    1.2 Allergic Rhinitis Drugs Segment by Type
        1.2.1 Global Allergic Rhinitis Drugs Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Antihistamines
        1.2.3 Intranasal Corticosteroids
        1.2.4 Immunotherapies
    1.3 Allergic Rhinitis Drugs Segment by Application
        1.3.1 Global Allergic Rhinitis Drugs Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
    1.4 Global Allergic Rhinitis Drugs Market Size Estimates and Forecasts
        1.4.1 Global Allergic Rhinitis Drugs Revenue 2017-2028
        1.4.2 Global Allergic Rhinitis Drugs Sales 2017-2028
        1.4.3 Allergic Rhinitis Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Allergic Rhinitis Drugs Market Competition by Manufacturers
    2.1 Global Allergic Rhinitis Drugs Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Allergic Rhinitis Drugs Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Allergic Rhinitis Drugs Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Allergic Rhinitis Drugs Manufacturing Sites, Area Served, Product Type
    2.5 Allergic Rhinitis Drugs Market Competitive Situation and Trends
        2.5.1 Allergic Rhinitis Drugs Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Allergic Rhinitis Drugs Players Market Share by Revenue
        2.5.3 Global Allergic Rhinitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Allergic Rhinitis Drugs Retrospective Market Scenario by Region
    3.1 Global Allergic Rhinitis Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Allergic Rhinitis Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Allergic Rhinitis Drugs Market Facts & Figures by Country
        3.3.1 North America Allergic Rhinitis Drugs Sales by Country
        3.3.2 North America Allergic Rhinitis Drugs Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Allergic Rhinitis Drugs Market Facts & Figures by Country
        3.4.1 Europe Allergic Rhinitis Drugs Sales by Country
        3.4.2 Europe Allergic Rhinitis Drugs Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Allergic Rhinitis Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific Allergic Rhinitis Drugs Sales by Region
        3.5.2 Asia Pacific Allergic Rhinitis Drugs Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Allergic Rhinitis Drugs Market Facts & Figures by Country
        3.6.1 Latin America Allergic Rhinitis Drugs Sales by Country
        3.6.2 Latin America Allergic Rhinitis Drugs Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Allergic Rhinitis Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa Allergic Rhinitis Drugs Sales by Country
        3.7.2 Middle East and Africa Allergic Rhinitis Drugs Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Allergic Rhinitis Drugs Historic Market Analysis by Type
    4.1 Global Allergic Rhinitis Drugs Sales Market Share by Type (2017-2022)
    4.2 Global Allergic Rhinitis Drugs Revenue Market Share by Type (2017-2022)
    4.3 Global Allergic Rhinitis Drugs Price by Type (2017-2022)
5 Global Allergic Rhinitis Drugs Historic Market Analysis by Application
    5.1 Global Allergic Rhinitis Drugs Sales Market Share by Application (2017-2022)
    5.2 Global Allergic Rhinitis Drugs Revenue Market Share by Application (2017-2022)
    5.3 Global Allergic Rhinitis Drugs Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 GlaxoSmithKline
        6.1.1 GlaxoSmithKline Corporation Information
        6.1.2 GlaxoSmithKline Description and Business Overview
        6.1.3 GlaxoSmithKline Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 GlaxoSmithKline Allergic Rhinitis Drugs Product Portfolio
        6.1.5 GlaxoSmithKline Recent Developments/Updates
    6.2 Sanofi
        6.2.1 Sanofi Corporation Information
        6.2.2 Sanofi Description and Business Overview
        6.2.3 Sanofi Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Sanofi Allergic Rhinitis Drugs Product Portfolio
        6.2.5 Sanofi Recent Developments/Updates
    6.3 ALK-Abelló
        6.3.1 ALK-Abelló Corporation Information
        6.3.2 ALK-Abelló Description and Business Overview
        6.3.3 ALK-Abelló Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 ALK-Abelló Allergic Rhinitis Drugs Product Portfolio
        6.3.5 ALK-Abelló Recent Developments/Updates
    6.4 Meda Pharmaceuticals
        6.4.1 Meda Pharmaceuticals Corporation Information
        6.4.2 Meda Pharmaceuticals Description and Business Overview
        6.4.3 Meda Pharmaceuticals Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Meda Pharmaceuticals Allergic Rhinitis Drugs Product Portfolio
        6.4.5 Meda Pharmaceuticals Recent Developments/Updates
    6.5 Adamis Pharmaceuticals
        6.5.1 Adamis Pharmaceuticals Corporation Information
        6.5.2 Adamis Pharmaceuticals Description and Business Overview
        6.5.3 Adamis Pharmaceuticals Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Adamis Pharmaceuticals Allergic Rhinitis Drugs Product Portfolio
        6.5.5 Adamis Pharmaceuticals Recent Developments/Updates
    6.6 Allergy Therapeutics
        6.6.1 Allergy Therapeutics Corporation Information
        6.6.2 Allergy Therapeutics Description and Business Overview
        6.6.3 Allergy Therapeutics Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Allergy Therapeutics Allergic Rhinitis Drugs Product Portfolio
        6.6.5 Allergy Therapeutics Recent Developments/Updates
    6.7 Almirall
        6.6.1 Almirall Corporation Information
        6.6.2 Almirall Description and Business Overview
        6.6.3 Almirall Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Almirall Allergic Rhinitis Drugs Product Portfolio
        6.7.5 Almirall Recent Developments/Updates
    6.8 Ampio
        6.8.1 Ampio Corporation Information
        6.8.2 Ampio Description and Business Overview
        6.8.3 Ampio Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Ampio Allergic Rhinitis Drugs Product Portfolio
        6.8.5 Ampio Recent Developments/Updates
    6.9 AstraZeneca
        6.9.1 AstraZeneca Corporation Information
        6.9.2 AstraZeneca Description and Business Overview
        6.9.3 AstraZeneca Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 AstraZeneca Allergic Rhinitis Drugs Product Portfolio
        6.9.5 AstraZeneca Recent Developments/Updates
    6.10 Amneal Pharmaceuticals
        6.10.1 Amneal Pharmaceuticals Corporation Information
        6.10.2 Amneal Pharmaceuticals Description and Business Overview
        6.10.3 Amneal Pharmaceuticals Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Amneal Pharmaceuticals Allergic Rhinitis Drugs Product Portfolio
        6.10.5 Amneal Pharmaceuticals Recent Developments/Updates
    6.11 Anergis
        6.11.1 Anergis Corporation Information
        6.11.2 Anergis Allergic Rhinitis Drugs Description and Business Overview
        6.11.3 Anergis Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Anergis Allergic Rhinitis Drugs Product Portfolio
        6.11.5 Anergis Recent Developments/Updates
    6.12 Apotex
        6.12.1 Apotex Corporation Information
        6.12.2 Apotex Allergic Rhinitis Drugs Description and Business Overview
        6.12.3 Apotex Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Apotex Allergic Rhinitis Drugs Product Portfolio
        6.12.5 Apotex Recent Developments/Updates
    6.13 Array BioPharma
        6.13.1 Array BioPharma Corporation Information
        6.13.2 Array BioPharma Allergic Rhinitis Drugs Description and Business Overview
        6.13.3 Array BioPharma Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Array BioPharma Allergic Rhinitis Drugs Product Portfolio
        6.13.5 Array BioPharma Recent Developments/Updates
    6.14 Aspen Pharmacare
        6.14.1 Aspen Pharmacare Corporation Information
        6.14.2 Aspen Pharmacare Allergic Rhinitis Drugs Description and Business Overview
        6.14.3 Aspen Pharmacare Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Aspen Pharmacare Allergic Rhinitis Drugs Product Portfolio
        6.14.5 Aspen Pharmacare Recent Developments/Updates
    6.15 Circassia Pharmaceuticals
        6.15.1 Circassia Pharmaceuticals Corporation Information
        6.15.2 Circassia Pharmaceuticals Allergic Rhinitis Drugs Description and Business Overview
        6.15.3 Circassia Pharmaceuticals Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Circassia Pharmaceuticals Allergic Rhinitis Drugs Product Portfolio
        6.15.5 Circassia Pharmaceuticals Recent Developments/Updates
    6.16 Dr Reddy's Laboratories
        6.16.1 Dr Reddy's Laboratories Corporation Information
        6.16.2 Dr Reddy's Laboratories Allergic Rhinitis Drugs Description and Business Overview
        6.16.3 Dr Reddy's Laboratories Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Dr Reddy's Laboratories Allergic Rhinitis Drugs Product Portfolio
        6.16.5 Dr Reddy's Laboratories Recent Developments/Updates
    6.17 Eddingpharm
        6.17.1 Eddingpharm Corporation Information
        6.17.2 Eddingpharm Allergic Rhinitis Drugs Description and Business Overview
        6.17.3 Eddingpharm Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Eddingpharm Allergic Rhinitis Drugs Product Portfolio
        6.17.5 Eddingpharm Recent Developments/Updates
    6.18 EMS
        6.18.1 EMS Corporation Information
        6.18.2 EMS Allergic Rhinitis Drugs Description and Business Overview
        6.18.3 EMS Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 EMS Allergic Rhinitis Drugs Product Portfolio
        6.18.5 EMS Recent Developments/Updates
    6.19 HAL Allergy
        6.19.1 HAL Allergy Corporation Information
        6.19.2 HAL Allergy Allergic Rhinitis Drugs Description and Business Overview
        6.19.3 HAL Allergy Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 HAL Allergy Allergic Rhinitis Drugs Product Portfolio
        6.19.5 HAL Allergy Recent Developments/Updates
    6.20 Inmunotek
        6.20.1 Inmunotek Corporation Information
        6.20.2 Inmunotek Allergic Rhinitis Drugs Description and Business Overview
        6.20.3 Inmunotek Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.20.4 Inmunotek Allergic Rhinitis Drugs Product Portfolio
        6.20.5 Inmunotek Recent Developments/Updates
    6.21 Genentech
        6.21.1 Genentech Corporation Information
        6.21.2 Genentech Allergic Rhinitis Drugs Description and Business Overview
        6.21.3 Genentech Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.21.4 Genentech Allergic Rhinitis Drugs Product Portfolio
        6.21.5 Genentech Recent Developments/Updates
    6.22 Greer Laboratories
        6.22.1 Greer Laboratories Corporation Information
        6.22.2 Greer Laboratories Allergic Rhinitis Drugs Description and Business Overview
        6.22.3 Greer Laboratories Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.22.4 Greer Laboratories Allergic Rhinitis Drugs Product Portfolio
        6.22.5 Greer Laboratories Recent Developments/Updates
    6.23 Glenmark Pharmaceuticals
        6.23.1 Glenmark Pharmaceuticals Corporation Information
        6.23.2 Glenmark Pharmaceuticals Allergic Rhinitis Drugs Description and Business Overview
        6.23.3 Glenmark Pharmaceuticals Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.23.4 Glenmark Pharmaceuticals Allergic Rhinitis Drugs Product Portfolio
        6.23.5 Glenmark Pharmaceuticals Recent Developments/Updates
    6.24 Hanmi Pharmaceuticals
        6.24.1 Hanmi Pharmaceuticals Corporation Information
        6.24.2 Hanmi Pharmaceuticals Allergic Rhinitis Drugs Description and Business Overview
        6.24.3 Hanmi Pharmaceuticals Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.24.4 Hanmi Pharmaceuticals Allergic Rhinitis Drugs Product Portfolio
        6.24.5 Hanmi Pharmaceuticals Recent Developments/Updates
    6.25 Hisamitsu Pharmaceutical
        6.25.1 Hisamitsu Pharmaceutical Corporation Information
        6.25.2 Hisamitsu Pharmaceutical Allergic Rhinitis Drugs Description and Business Overview
        6.25.3 Hisamitsu Pharmaceutical Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.25.4 Hisamitsu Pharmaceutical Allergic Rhinitis Drugs Product Portfolio
        6.25.5 Hisamitsu Pharmaceutical Recent Developments/Updates
    6.26 Intas Pharmaceuticals
        6.26.1 Intas Pharmaceuticals Corporation Information
        6.26.2 Intas Pharmaceuticals Allergic Rhinitis Drugs Description and Business Overview
        6.26.3 Intas Pharmaceuticals Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.26.4 Intas Pharmaceuticals Allergic Rhinitis Drugs Product Portfolio
        6.26.5 Intas Pharmaceuticals Recent Developments/Updates
    6.27 Novartis
        6.27.1 Novartis Corporation Information
        6.27.2 Novartis Allergic Rhinitis Drugs Description and Business Overview
        6.27.3 Novartis Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.27.4 Novartis Allergic Rhinitis Drugs Product Portfolio
        6.27.5 Novartis Recent Developments/Updates
7 Allergic Rhinitis Drugs Manufacturing Cost Analysis
    7.1 Allergic Rhinitis Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Allergic Rhinitis Drugs
    7.4 Allergic Rhinitis Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Allergic Rhinitis Drugs Distributors List
    8.3 Allergic Rhinitis Drugs Customers
9 Allergic Rhinitis Drugs Market Dynamics
    9.1 Allergic Rhinitis Drugs Industry Trends
    9.2 Allergic Rhinitis Drugs Market Drivers
    9.3 Allergic Rhinitis Drugs Market Challenges
    9.4 Allergic Rhinitis Drugs Market Restraints
10 Global Market Forecast
    10.1 Allergic Rhinitis Drugs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Allergic Rhinitis Drugs by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Allergic Rhinitis Drugs by Type (2023-2028)
    10.2 Allergic Rhinitis Drugs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Allergic Rhinitis Drugs by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Allergic Rhinitis Drugs by Application (2023-2028)
    10.3 Allergic Rhinitis Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Allergic Rhinitis Drugs by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Allergic Rhinitis Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Allergic Rhinitis Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Allergic Rhinitis Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Allergic Rhinitis Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Allergic Rhinitis Drugs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Allergic Rhinitis Drugs Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Allergic Rhinitis Drugs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Allergic Rhinitis Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Allergic Rhinitis Drugs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Allergic Rhinitis Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Allergic Rhinitis Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers Allergic Rhinitis Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Allergic Rhinitis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allergic Rhinitis Drugs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Allergic Rhinitis Drugs Sales by Region (2017-2022) & (K Units)
    Table 16. Global Allergic Rhinitis Drugs Sales Market Share by Region (2017-2022)
    Table 17. Global Allergic Rhinitis Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Allergic Rhinitis Drugs Revenue Market Share by Region (2017-2022)
    Table 19. North America Allergic Rhinitis Drugs Sales by Country (2017-2022) & (K Units)
    Table 20. North America Allergic Rhinitis Drugs Sales Market Share by Country (2017-2022)
    Table 21. North America Allergic Rhinitis Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Allergic Rhinitis Drugs Revenue Market Share by Country (2017-2022)
    Table 23. Europe Allergic Rhinitis Drugs Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Allergic Rhinitis Drugs Sales Market Share by Country (2017-2022)
    Table 25. Europe Allergic Rhinitis Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Allergic Rhinitis Drugs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Allergic Rhinitis Drugs Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Allergic Rhinitis Drugs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Allergic Rhinitis Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Allergic Rhinitis Drugs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Allergic Rhinitis Drugs Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Allergic Rhinitis Drugs Sales Market Share by Country (2017-2022)
    Table 33. Latin America Allergic Rhinitis Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Allergic Rhinitis Drugs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Allergic Rhinitis Drugs Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Allergic Rhinitis Drugs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Allergic Rhinitis Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Allergic Rhinitis Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Global Allergic Rhinitis Drugs Sales by Type (2017-2022) & (K Units)
    Table 40. Global Allergic Rhinitis Drugs Sales Market Share by Type (2017-2022)
    Table 41. Global Allergic Rhinitis Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Allergic Rhinitis Drugs Revenue Share by Type (2017-2022)
    Table 43. Global Allergic Rhinitis Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Allergic Rhinitis Drugs Sales (K Units) by Application (2017-2022)
    Table 45. Global Allergic Rhinitis Drugs Sales Market Share by Application (2017-2022)
    Table 46. Global Allergic Rhinitis Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Allergic Rhinitis Drugs Revenue Share by Application (2017-2022)
    Table 48. Global Allergic Rhinitis Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 49. GlaxoSmithKline Corporation Information
    Table 50. GlaxoSmithKline Description and Business Overview
    Table 51. GlaxoSmithKline Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. GlaxoSmithKline Allergic Rhinitis Drugs Product
    Table 53. GlaxoSmithKline Recent Developments/Updates
    Table 54. Sanofi Corporation Information
    Table 55. Sanofi Description and Business Overview
    Table 56. Sanofi Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Sanofi Allergic Rhinitis Drugs Product
    Table 58. Sanofi Recent Developments/Updates
    Table 59. ALK-Abelló Corporation Information
    Table 60. ALK-Abelló Description and Business Overview
    Table 61. ALK-Abelló Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. ALK-Abelló Allergic Rhinitis Drugs Product
    Table 63. ALK-Abelló Recent Developments/Updates
    Table 64. Meda Pharmaceuticals Corporation Information
    Table 65. Meda Pharmaceuticals Description and Business Overview
    Table 66. Meda Pharmaceuticals Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Meda Pharmaceuticals Allergic Rhinitis Drugs Product
    Table 68. Meda Pharmaceuticals Recent Developments/Updates
    Table 69. Adamis Pharmaceuticals Corporation Information
    Table 70. Adamis Pharmaceuticals Description and Business Overview
    Table 71. Adamis Pharmaceuticals Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Adamis Pharmaceuticals Allergic Rhinitis Drugs Product
    Table 73. Adamis Pharmaceuticals Recent Developments/Updates
    Table 74. Allergy Therapeutics Corporation Information
    Table 75. Allergy Therapeutics Description and Business Overview
    Table 76. Allergy Therapeutics Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. Allergy Therapeutics Allergic Rhinitis Drugs Product
    Table 78. Allergy Therapeutics Recent Developments/Updates
    Table 79. Almirall Corporation Information
    Table 80. Almirall Description and Business Overview
    Table 81. Almirall Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. Almirall Allergic Rhinitis Drugs Product
    Table 83. Almirall Recent Developments/Updates
    Table 84. Ampio Corporation Information
    Table 85. Ampio Description and Business Overview
    Table 86. Ampio Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. Ampio Allergic Rhinitis Drugs Product
    Table 88. Ampio Recent Developments/Updates
    Table 89. AstraZeneca Corporation Information
    Table 90. AstraZeneca Description and Business Overview
    Table 91. AstraZeneca Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 92. AstraZeneca Allergic Rhinitis Drugs Product
    Table 93. AstraZeneca Recent Developments/Updates
    Table 94. Amneal Pharmaceuticals Corporation Information
    Table 95. Amneal Pharmaceuticals Description and Business Overview
    Table 96. Amneal Pharmaceuticals Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 97. Amneal Pharmaceuticals Allergic Rhinitis Drugs Product
    Table 98. Amneal Pharmaceuticals Recent Developments/Updates
    Table 99. Anergis Corporation Information
    Table 100. Anergis Description and Business Overview
    Table 101. Anergis Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 102. Anergis Allergic Rhinitis Drugs Product
    Table 103. Anergis Recent Developments/Updates
    Table 104. Apotex Corporation Information
    Table 105. Apotex Description and Business Overview
    Table 106. Apotex Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 107. Apotex Allergic Rhinitis Drugs Product
    Table 108. Apotex Recent Developments/Updates
    Table 109. Array BioPharma Corporation Information
    Table 110. Array BioPharma Description and Business Overview
    Table 111. Array BioPharma Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. Array BioPharma Allergic Rhinitis Drugs Product
    Table 113. Array BioPharma Recent Developments/Updates
    Table 114. Aspen Pharmacare Corporation Information
    Table 115. Aspen Pharmacare Description and Business Overview
    Table 116. Aspen Pharmacare Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. Aspen Pharmacare Allergic Rhinitis Drugs Product
    Table 118. Aspen Pharmacare Recent Developments/Updates
    Table 119. Circassia Pharmaceuticals Corporation Information
    Table 120. Circassia Pharmaceuticals Description and Business Overview
    Table 121. Circassia Pharmaceuticals Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. Circassia Pharmaceuticals Allergic Rhinitis Drugs Product
    Table 123. Circassia Pharmaceuticals Recent Developments/Updates
    Table 124. Dr Reddy's Laboratories Corporation Information
    Table 125. Dr Reddy's Laboratories Description and Business Overview
    Table 126. Dr Reddy's Laboratories Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. Dr Reddy's Laboratories Allergic Rhinitis Drugs Product
    Table 128. Dr Reddy's Laboratories Recent Developments/Updates
    Table 129. Eddingpharm Corporation Information
    Table 130. Eddingpharm Description and Business Overview
    Table 131. Eddingpharm Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 132. Eddingpharm Allergic Rhinitis Drugs Product
    Table 133. Eddingpharm Recent Developments/Updates
    Table 134. EMS Corporation Information
    Table 135. EMS Description and Business Overview
    Table 136. EMS Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 137. EMS Allergic Rhinitis Drugs Product
    Table 138. EMS Recent Developments/Updates
    Table 139. HAL Allergy Corporation Information
    Table 140. HAL Allergy Description and Business Overview
    Table 141. HAL Allergy Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 142. HAL Allergy Allergic Rhinitis Drugs Product
    Table 143. HAL Allergy Recent Developments/Updates
    Table 144. Inmunotek Corporation Information
    Table 145. Inmunotek Description and Business Overview
    Table 146. Inmunotek Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 147. Inmunotek Allergic Rhinitis Drugs Product
    Table 148. Inmunotek Recent Developments/Updates
    Table 149. Genentech Corporation Information
    Table 150. Genentech Description and Business Overview
    Table 151. Genentech Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 152. Genentech Allergic Rhinitis Drugs Product
    Table 153. Genentech Recent Developments/Updates
    Table 154. Greer Laboratories Corporation Information
    Table 155. Greer Laboratories Description and Business Overview
    Table 156. Greer Laboratories Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 157. Greer Laboratories Allergic Rhinitis Drugs Product
    Table 158. Greer Laboratories Recent Developments/Updates
    Table 159. Glenmark Pharmaceuticals Corporation Information
    Table 160. Glenmark Pharmaceuticals Description and Business Overview
    Table 161. Glenmark Pharmaceuticals Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 162. Glenmark Pharmaceuticals Allergic Rhinitis Drugs Product
    Table 163. Glenmark Pharmaceuticals Recent Developments/Updates
    Table 164. Hanmi Pharmaceuticals Corporation Information
    Table 165. Hanmi Pharmaceuticals Description and Business Overview
    Table 166. Hanmi Pharmaceuticals Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 167. Hanmi Pharmaceuticals Allergic Rhinitis Drugs Product
    Table 168. Hanmi Pharmaceuticals Recent Developments/Updates
    Table 169. Hisamitsu Pharmaceutical Corporation Information
    Table 170. Hisamitsu Pharmaceutical Description and Business Overview
    Table 171. Hisamitsu Pharmaceutical Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 172. Hisamitsu Pharmaceutical Allergic Rhinitis Drugs Product
    Table 173. Hisamitsu Pharmaceutical Recent Developments/Updates
    Table 174. Intas Pharmaceuticals Corporation Information
    Table 175. Intas Pharmaceuticals Description and Business Overview
    Table 176. Intas Pharmaceuticals Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 177. Intas Pharmaceuticals Allergic Rhinitis Drugs Product
    Table 178. Intas Pharmaceuticals Recent Developments/Updates
    Table 179. Novartis Corporation Information
    Table 180. Novartis Description and Business Overview
    Table 181. Novartis Allergic Rhinitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 182. Novartis Allergic Rhinitis Drugs Product
    Table 183. Novartis Recent Developments/Updates
    Table 184. Production Base and Market Concentration Rate of Raw Material
    Table 185. Key Suppliers of Raw Materials
    Table 186. Allergic Rhinitis Drugs Distributors List
    Table 187. Allergic Rhinitis Drugs Customers List
    Table 188. Allergic Rhinitis Drugs Market Trends
    Table 189. Allergic Rhinitis Drugs Market Drivers
    Table 190. Allergic Rhinitis Drugs Market Challenges
    Table 191. Allergic Rhinitis Drugs Market Restraints
    Table 192. Global Allergic Rhinitis Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 193. Global Allergic Rhinitis Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 194. Global Allergic Rhinitis Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 195. Global Allergic Rhinitis Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 196. Global Allergic Rhinitis Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 197. Global Allergic Rhinitis Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 198. Global Allergic Rhinitis Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 199. Global Allergic Rhinitis Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 200. Global Allergic Rhinitis Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 201. Global Allergic Rhinitis Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 202. Global Allergic Rhinitis Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 203. Global Allergic Rhinitis Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 204. Research Programs/Design for This Report
    Table 205. Key Data Information from Secondary Sources
    Table 206. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Allergic Rhinitis Drugs
    Figure 2. Global Allergic Rhinitis Drugs Market Share by Type in 2021 & 2028
    Figure 3. Antihistamines Product Picture
    Figure 4. Intranasal Corticosteroids Product Picture
    Figure 5. Immunotherapies Product Picture
    Figure 6. Global Allergic Rhinitis Drugs Market Share by Application in 2021 & 2028
    Figure 7. Hospital Pharmacy
    Figure 8. Retail Pharmacy
    Figure 9. Online Pharmacy
    Figure 10. Global Allergic Rhinitis Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Allergic Rhinitis Drugs Market Size (2017-2028) & (US$ Million)
    Figure 12. Global Allergic Rhinitis Drugs Sales (2017-2028) & (K Units)
    Figure 13. Allergic Rhinitis Drugs Sales Share by Manufacturers in 2021
    Figure 14. Global Allergic Rhinitis Drugs Revenue Share by Manufacturers in 2021
    Figure 15. The Global 5 and 10 Largest Allergic Rhinitis Drugs Players: Market Share by Revenue in 2021
    Figure 16. Allergic Rhinitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Allergic Rhinitis Drugs Sales Market Share by Region (2017-2022)
    Figure 18. Global Allergic Rhinitis Drugs Sales Market Share by Region in 2021
    Figure 19. Global Allergic Rhinitis Drugs Revenue Market Share by Region (2017-2022)
    Figure 20. Global Allergic Rhinitis Drugs Revenue Market Share by Region in 2021
    Figure 21. U.S. Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Canada Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Germany Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. France Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. U.K. Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Italy Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Russia Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. China Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Japan Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. South Korea Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. India Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Australia Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Taiwan Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Indonesia Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Thailand Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Malaysia Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Philippines Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Vietnam Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Mexico Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Brazil Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Argentina Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Turkey Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Saudi Arabia Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. U.A.E Allergic Rhinitis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Sales Market Share of Allergic Rhinitis Drugs by Type (2017-2022)
    Figure 46. Manufacturing Cost Structure of Allergic Rhinitis Drugs
    Figure 47. Manufacturing Process Analysis of Allergic Rhinitis Drugs
    Figure 48. Allergic Rhinitis Drugs Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline
Sanofi
ALK-Abelló
Meda Pharmaceuticals
Adamis Pharmaceuticals
Allergy Therapeutics
Almirall
Ampio
AstraZeneca
Amneal Pharmaceuticals
Anergis
Apotex
Array BioPharma
Aspen Pharmacare
Circassia Pharmaceuticals
Dr Reddy's Laboratories
Eddingpharm
EMS
HAL Allergy
Inmunotek
Genentech
Greer Laboratories
Glenmark Pharmaceuticals
Hanmi Pharmaceuticals
Hisamitsu Pharmaceutical
Intas Pharmaceuticals
Novartis
Frequently Asked Questions
Allergic Rhinitis Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Allergic Rhinitis Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Allergic Rhinitis Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports